1. Home
  2. List
Reference Patent

Reference - List

  • 29 Hits
  • 検索条件 : 絞込み (MeSH = Neovascularization, Pathologic / genetics)
Species Resource Title
Mice RBRC02975 Angiogenic Factor AGGF1 Activates Autophagy with an Essential Role in Therapeutic Angiogenesis for Heart Disease.
DNA material CSII-CMV-MCS-IRES2-Bsd (RDB04385) , pCMV-VSV-G-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394) Development of Human CBF1-Targeting Single-Stranded DNA Aptamers with Antiangiogenic Activity In Vitro.
DNA material CSII-CMV-MCS-IRES2-Bsd (RDB04385) DPY19L3 promotes vasculogenic mimicry by its C-mannosyltransferase activity.
Human and Animal Cells , DNA material 293T(RCB2202) , CSII-CMV-MCS (RDB4377) , CSII-CMV-MCS-IRES2-Bsd (RDB4385) , pSpCas9n_cofilin sgRNA1 (RDB20017) , pSpCas9n_cofilin sgRNA2 (RDB20018) , CSII-CMV-MCS_cofilin (RDB20019) , CSII-CMV-MCS-IRES2-Bsd_Cas9-resistant cofilin (RDB20020) , CSII-CMV-MCS-IRES2-Bsd_Cas10-resistant S3E cofilin (RDB20021) Cofilin promotes vasculogenic mimicry by regulating the actin cytoskeleton in human breast cancer cells.
Human and Animal Cells SK-MEL-28(RCB1930) Methionine aminopeptidase‑2 is a pivotal regulator of vasculogenic mimicry.
Human and Animal Cells MCF7(RCB1904) ErbB4-mediated regulation of vasculogenic mimicry capability in breast cancer cells.
Human and Animal Cells JHUCS-1(RCB1547) miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas.
Human and Animal Cells B16F1(RCB2649) , B16F10(RCB2630) , B16F10/mGM(RCB1158) Acceleration of tumor growth due to dysfunction in M1 macrophages and enhanced angiogenesis in an animal model of autoimmune disease.
Human and Animal Cells CACO-2(RCB0988) Protease-activated receptor-2 accelerates intestinal tumor formation through activation of nuclear factor-κB signaling and tumor angiogenesis in ApcMin/+ mice.
Human and Animal Cells SCCKN(RCB0441) Combination Cancer Therapy of a Del1 Fragment and Cisplatin Enhanced Therapeutic Efficiency In Vivo.
Human and Animal Cells JHOC-7(RCB1688) , JHOC-9(RCB2226) MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.
Human and Animal Cells B901L(RCB3530) MALDI mass spectrometry imaging of erlotinib administered in combination with bevacizumab in xenograft mice bearing B901L, EGFR-mutated NSCLC cells.
Human and Animal Cells CCF-STTG1(RCB1977) Expression of CXCL12 on pseudopalisading cells and proliferating microvessels in glioblastomas: an accelerated growth factor in glioblastomas.
Human and Animal Cells Saos-2 Epigenetic modulators hydralazine and sodium valproate act synergistically in VEGI-mediated anti-angiogenesis and VEGF interference in human osteosarcoma and vascular endothelial cells.
DNA material pCAcc-Luc+ (RDB02443) Polyplex micelle installing intracellular self-processing functionalities without free catiomers for safe and efficient systemic gene therapy through tumor vasculature targeting.
Human and Animal Cells MH7A(RCB1512) Inhibition of the insulin-like growth factor system is a potential therapy for rheumatoid arthritis.
Human and Animal Cells CACO-2(RCB0988) , LoVo(RCB1939) Vasohibin-1 increases the malignant potential of colorectal cancer and is a biomarker of poor prognosis.
Human and Animal Cells DU145(RCB2143) Zinc finger MYND-type containing 8 promotes tumour angiogenesis via induction of vascular endothelial growth factor-A expression.
Human and Animal Cells TE-8(RCB2098) , TE-9(RCB1988) , TE-10(RCB2099) , TE-11(RCB2100) , TE-15(RCB19519 Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma.
Human and Animal Cells GSU(RCB2278) , Kato III(RCB2088) , KE-97(RCB1435) , MKN45(RCB1001) , NUGC-4(RCB1939) A novel inhibitor of c-Met and VEGF receptor tyrosine kinases with a broad spectrum of in vivo antitumor activities.